Related Experiment Video
Updated: Feb 14, 2026

Customization of Aspergillus niger Morphology Through Addition of Talc Micro Particles
Published on: March 15, 2012
Species of Aspergillus section Aspergillus from clinical samples in the United States
João P Z Siqueira1,2, Deanna A Sutton3, Josepa Gené1
1Unitat de Micologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain.
Abstract:
The diversity of Aspergillus species in clinical samples is continuously increasing. Species under the former name Eurotium, currently accommodated in section Aspergillus of the genus Aspergillus, are xerophilic fungi widely found in the human environment and able to grow on substrates with low water activity. However, their prevalence in the clinical setting is poorly known. We have studied the presence of these species in a set of clinical samples from the United States using a multilocus sequence analysis based on the internal transcribed spacer (ITS) region of the rRNA, and fragments of the genes β-tubulin (BenA), calmodulin (CaM), and polymerase II second largest subunit (RPB2). A total of 25 isolates were studied and identified as follows: A. montevidensis (44%), A. chevalieri (36%), A. pseudoglaucus (8%), and A. costiformis (4%). A new species Aspergillus microperforatus is also proposed, which represented 8% of the isolates studied and is characterized by uniseriate conidial heads, subglobose to pyriform vesicles, rough conidia, globose to subglobose cleistothecia, and lenticular and smooth ascospores. The in vitro antifungal activity of eight clinically available antifungals was also determined against these isolates, with the echinocandins and posaconazole having the most potent activity.
Insights
This study identifies Aspergillus species, including a new species Aspergillus microperforatus, in clinical samples. Echinocandins and posaconazole show potent antifungal activity against these xerophilic fungi.
Area of Science:
- Mycology
- Clinical Microbiology
Background:
- Xerophilic fungi in the Aspergillus genus (formerly Eurotium) are common environmental contaminants.
- Their prevalence and clinical significance in patient samples are not well-established.
Purpose of the Study:
- To investigate the diversity of Aspergillus species in clinical samples from the United States.
- To characterize a newly proposed species, Aspergillus microperforatus.
- To evaluate the in vitro antifungal susceptibility of clinical isolates.
Main Methods:
- Multilocus sequence analysis using internal transcribed spacer (ITS), beta-tubulin (BenA), calmodulin (CaM), and RNA polymerase II largest subunit (RPB2) genes.
- Identification of 25 clinical isolates.
- In vitro antifungal susceptibility testing of eight available antifungal agents.
Main Results:
- Aspergillus montevidensis (44%) and Aspergillus chevalieri (36%) were the most prevalent species.
- A new species, Aspergillus microperforatus (8%), was described.
- Echinocandins and posaconazole demonstrated the highest in vitro activity against the studied isolates.
Conclusions:
- This study expands the understanding of Aspergillus species diversity in clinical settings.
- Aspergillus microperforatus is a newly identified species with potential clinical relevance.
- Specific antifungal agents show promising activity against these xerophilic fungi.
Related Concept Videos
What is a Species?
Keystone Species
Formation of Species
Measurement: Derived Units
Measurement: Standard Units
Units of Measurement
There are various well-known historical measurement systems, such as the Babylonian system, the Roman system, the Egyptian system, the Olympian system, the British system, and the Indus...

